Webinar - Fast CARs: Streamlining Discovery with Mammalian Cell Libraries and Functional Single-Cell Screening

While CAR T cell therapies have achieved up to 90% complete response rates in hematologic malignancies, translating this success to solid tumors remains a major challenge due to limited antigen targets and the inefficiencies of traditional screening methods like phage display, which can take months and often yield non-functional CARs.

In this webinar, we introduce a rapid, mammalian display workflow that combines MaxCyte’s Flow Electroporation® technology with Bruker’s Beacon® optofluidic platform for live single-cell functional analysis. This approach enables the creation of high-diversity CAR T cell libraries and the functional screening of solid tumor–specific CARs, dramatically shortening discovery timelines.

The result: de novo identification and validation of functional CAR constructs in as little as six weeks, with scalable automation and high-dimensional data capture, making it accessible for both translational and industrial research environments.